| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 463 | 517 | 306 | 290 | | Cost of Revenue | 278 | 270 | 300 | 253 | | | Gross Profit | 184 | 247 | 6 | 37 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,200 | 1,413 | 1,630 | 1,112 | | Non Recurring | 2,260 | 156 | 2,100 | 1,480 | | Others | 286 | 296 | 187 | (605) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,562) | (1,617) | (3,910) | (1,951) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 58 | 17 | 21 | (119) | | Earnings Before Interest And Taxes | (3,553) | (1,600) | (3,889) | (2,070) | | Interest Expense |
-
|
-
|
-
| 12 | | Income Before Tax | (3,553) | (1,600) | (3,889) | (2,082) | | Income Tax Expense |
-
|
-
|
-
| 7,032 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,403) | (1,600) | (3,889) | (9,114) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,403) | (1,600) | (3,889) | (9,114) | | Preferred Stock And Other Adjustments | 2 |
-
| (2) |
-
| | | Net Income Applicable To Common Shares | ($3,401) | ($1,600) | ($3,891) | ($9,114) |
|
0.23% Nasdaq 
0.06 (1.37%) 
Income Statement
